Form 8-K - Current report:
SEC Accession No. 0000950170-23-023023
Filing Date
2023-05-18
Accepted
2023-05-18 16:06:45
Documents
12
Period of Report
2023-05-12
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K oncr-20230512.htm   iXBRL 8-K 58859
  Complete submission text file 0000950170-23-023023.txt   177464

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20230512_pre.xml EX-101.PRE 9830
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20230512_lab.xml EX-101.LAB 13350
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20230512.xsd EX-101.SCH 2454
6 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20230512_htm.xml XML 4691
Mailing Address 4 CORPORATE DRIVE ANDOVER MA 01810
Business Address 4 CORPORATE DRIVE ANDOVER MA 01810 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

EIN.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39575 | Film No.: 23936093
SIC: 2834 Pharmaceutical Preparations